ArticleNature cancer2022
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Abstract readPublished Erratum
In one paragraph
Article in Nature cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.Cancer immunology, immunotherapy : CII · 2023Article
- Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice.Microbial cell factories · 2023Article
Corrections and comments
- Erratum for
Authors and funding
36 authors.
Thomas Walle *Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.ORCID http://orcid.org/0000-0003-4835-955X
Sunanjay Bajaj *Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Joscha A KraskeDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8567-6020
Thomas RösnerDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Christiane S CussighDepartment of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Katharina A KälberDepartment of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Lisa Jasmin MüllerDepartment of Hematology, University Hospital Heidelberg, Heidelberg, Germany.
Sophia Boyoung StrobelDepartment of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Jana BurghausDepartment of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Stefan M KallenbergerDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Christoph K Stein-ThöringerDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Maximilian JenzerDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Antonia SchubertDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Steffen KahleDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Anja WilliamsDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Birgit HoylerClinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lin ZielskeNCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Renate SkatulaNCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Stefanie SawallClinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Mathias F LeberClinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Russell Z KunesDepartment of Statistics, Columbia University, New York, NY, USA.
Johannes KrisamInstitute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Carlo FremdDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Andreas SchneeweissDivision of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Jürgen KraussDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Leonidas ApostolidisDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Anne Katrin BergerDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Georg M HaagDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Stefanie ZschäbitzDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Niels HalamaDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0344-6027
Christoph SpringfeldDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Romy KirstenNCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Jessica C HasselDepartment of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Dirk JägerDepartment of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
NCT ANTICIPATE Investigators
Guy UngerechtsClinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.